Katie Lei

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy (2008)

Camporota, Luigi, Corno, Eleonora, Menaldo, Eleonora, Smith, John, Lei, Katie, Beale, Richard, ...

Abstract Introduction Drotrecogin alfa (activated) (DrotAA) is licensed in the United States and the European Union for the treatment of severe sepsis with multiple organ failure. Patients with...

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

Camporota, Luigi, Corno, Eleonora, Menaldo, Eleonora, Smith, John, Lei, Katie, Beale, Richard, ...